| Literature DB >> 28604754 |
T Sakurai, K Isogaya, S Sakai, M Morikawa, Y Morishita, S Ehata, K Miyazono, D Koinuma.
Abstract
This corrects the article DOI: 10.1038/onc.2016.35.Entities:
Year: 2017 PMID: 28604754 PMCID: PMC5582209 DOI: 10.1038/onc.2017.191
Source DB: PubMed Journal: Oncogene ISSN: 0950-9232 Impact factor: 9.867
Figure 2(f) H441 cells were transfected with human RBM47 promoter-reporter construct in combination with control or TTF-1 siRNAs (siTTF-1#1 (HSS144278), siTTF-1#3 (HSS144277) and siTTF-1#4 (HSS144279; Thermo Fisher Scientific)). At 48 h after transfection, cells were collected and assayed for luciferase activities. siCT: control siRNA. Averages and standard deviations of the two independent experiments were shown for each condition. The Tukey−Kramer test of the R program (http://www.r-project.org/) was used for multiple comparisons of the data. F-test was performed for the equality of variances.